Current Science

Open Access Open Access  Restricted Access Subscription Access

Towards Health for All:Cost-Effective and Innovative Treatment of Diabetes Shows the Pathway


Affiliations
1 M.S. Swaminathan Research Foundation, Taramani, Chennai 600 113, India
 

While the M.S. Swaminathan Research Foundation (MSSRF) has been developing and refining ecofriendly and socially inclusive strategies to achieve a 'zero hunger' India, the 'Voluntary Health Service' (VHS) in the neighbourhood of MSSRF has been focusing on providing quality health care to patients who are too poor to get medical treatment as those with adequate means. On the food front, it is remarkable that India has implemented the 'Right to Food Act 2012' with homegrown food through scientific endeavours and accomplishments. The situation with health care and medical treatment is quite different with the drugs developed by multinational companies, their undesirable side-effects as well as their cost beyond the means of millions of Indians. Under these circumstances, particularly with regard to the treatment and management of both type-1 and type-2 diabetes, the TAG-VHS Chennai, has already made remarkable progress. Towards the goal of successful treatment and sustainable management of diabetes, the TAG-VHS has introduced cost-effective integrative system of medicines (ayurveda, dynamic acupuncture mediated metaphysical energy-healing therapies and limited use of relatively safer allopathic drugs). The validation of the effectiveness of various combinations and modalities of the systems of medicine is based on the 'treatment outcome' without adverse side effects. The limitations of randomized clinical trials are discussed with examples and scientific references. Even though TAG-VHS employs cost-effective treatment schedules, there is still the need for necessary financial base. In order to create this financial support base, it has also innovated a scheme called the 'Grand Health Ensurance' (GHE) that is a revolutionary, completely transparent and inclusive health ensuring model where the affordable persons pay 1% of their total income per annum which automatically covers Health Ensurance of 1-2 persons for 1 year. This paper discusses how the cost-effective, harmful sideeffects-free integrative systems of medicine coupled with GHE would provide a sustainable path to achieve the goal of 'health for all'.

Keywords

Adverse Side Effects, Anti-Diabetic Drugs, Cost-Effective Treatment, Diabetes Type-1 and 2, Grand Health Ensurance Model, Health for all, TAG-Voluntary Health Service.
User
Notifications
Font Size

  • Swaminathan, M. S., From Green to Evergreen Revolution: Indian Agriculture: Performance and Emerging Challenges, Academic Foundation, New Delhi 2010, p. 410.

  • Raskin, P. et al., A randomized trial of Rosiglitazone (RSG) therapy in patients with inadequately controlled insulin-treated Type 2 Diabetes. Diabetes Care, 2001, 24, 1226–1232.

  • Nissen, S. E., The rise and fall of rosiglitazone. Eur. Heart J., 2010, 31, 773–776.

  • Anon., Lancet, Editorial, Strengthening the credibility of clinical research, 2010, 375, 1225; www.thelancet.com.vol375, 10 April 2010.

  • Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial, National Heart, Lund and Blood Institute, 2008, US Department of Health, Human Services.

  • Krishnaswami, C. V., The tale of two diseases – Type 1 and type2 diabetes mellitus. Curr. Sci., 2016, 110(9), 1599–1600.

  • Krishnaswami, C. V., Diabetes mellitus in the third millennium – Quo Vadis Domini?’ In Future of Health Care (How to Restore Wholeness) (eds Abraham, J., Ramakrishnan, M. and Krishnaswami, C. V.), Proc. Public Symp., Tamil Nadu Chapter of National Academy of Sciences, Chennai, India, 2000.

  • Krishnaswami, C. V., The wonder drug that was not. The Hindu, 5 July 2001.

  • The British Medical Journal, ‘The war on drugs has failed: doctors should lead calls for drug policy reform, 14 November 2016; doi: https://doi.org/10.1136/bmj.i6067.

  • Gale, E. A., Dying of diabetes. The Lancet, 2006, 368, 1626–1628.

  • Pendsey, S., Where are all the girls with diabetes? Diabetes Voice, 1998, 11, 4–5.

  • Krishnaswami, C. V., Dying of diabetes. The Lancet, 2007, 369, 461.

  • Gale, E. A., Author’s Reply. The Lancet, 2007, 369, 461.

  • Krishnaswami, C. V., The RCPE UK Consensus Statement on Diabetes opens up more questions. J.R. College Physicians Edinb., 2010, 40, 283–286; doi:10.4997/JRCPE2010.321.

  • Krishnaswami, C. V., The Hindu, 12 April 2012.

  • Krishnaswami, C. V., Ramesh, C., Sampoornam, B., Ganesan, A. and Rajan, V., Metaphysical energy therapy in the treatment of cranial nerve palsies with special reference to Bell’s palsy. J. Biosci. Med., 2016, 4, 77–84.

  • Krishnaswami, C. V. et al., Fasting C-peptide response, and its clinical impact in type I diabetes to a novel metaphysical energy healing therapy-preliminary experience and observations. J. Diabetes Mellitus, 2016, 6, 90–99.

  • Jayasundar, R., If systems approach is the way forward, what can the ayurvedic theory of tridosha teach us? Curr. Sci., 2017, 112, 1127–1133.

  • Valiathan, M. S., Ayurvedic biology. Curr. Sci., 2016, 110, 2043–2044.

  • Rotti, H. and 23 others, DNA methylation analysis of phenotype specific stratified Indian population. J. Translational Med., 2015, 13, 151; doi:10.1186/s12967-015-0506-0.

  • Ayers, D. and Day, P. J., Systems medicine: The application of systems biology approaches for modern medical research and drug development. Mol. Biol. Intl., 2015, 2015, 1–8.

  • Krishnaswami, C. V., Sampoornam, B., Ramesh, C., Venkatesan, P., Grand Health Insurance – for sustainable health security, improving health and life expectancy – for people of India. Anusandhan, 2017, VI(XI), 1109–1117.


Abstract Views: 388

PDF Views: 127




  • Towards Health for All:Cost-Effective and Innovative Treatment of Diabetes Shows the Pathway

Abstract Views: 388  |  PDF Views: 127

Authors

P. C. Kesavan
M.S. Swaminathan Research Foundation, Taramani, Chennai 600 113, India
M. S. Swaminathan
M.S. Swaminathan Research Foundation, Taramani, Chennai 600 113, India

Abstract


While the M.S. Swaminathan Research Foundation (MSSRF) has been developing and refining ecofriendly and socially inclusive strategies to achieve a 'zero hunger' India, the 'Voluntary Health Service' (VHS) in the neighbourhood of MSSRF has been focusing on providing quality health care to patients who are too poor to get medical treatment as those with adequate means. On the food front, it is remarkable that India has implemented the 'Right to Food Act 2012' with homegrown food through scientific endeavours and accomplishments. The situation with health care and medical treatment is quite different with the drugs developed by multinational companies, their undesirable side-effects as well as their cost beyond the means of millions of Indians. Under these circumstances, particularly with regard to the treatment and management of both type-1 and type-2 diabetes, the TAG-VHS Chennai, has already made remarkable progress. Towards the goal of successful treatment and sustainable management of diabetes, the TAG-VHS has introduced cost-effective integrative system of medicines (ayurveda, dynamic acupuncture mediated metaphysical energy-healing therapies and limited use of relatively safer allopathic drugs). The validation of the effectiveness of various combinations and modalities of the systems of medicine is based on the 'treatment outcome' without adverse side effects. The limitations of randomized clinical trials are discussed with examples and scientific references. Even though TAG-VHS employs cost-effective treatment schedules, there is still the need for necessary financial base. In order to create this financial support base, it has also innovated a scheme called the 'Grand Health Ensurance' (GHE) that is a revolutionary, completely transparent and inclusive health ensuring model where the affordable persons pay 1% of their total income per annum which automatically covers Health Ensurance of 1-2 persons for 1 year. This paper discusses how the cost-effective, harmful sideeffects-free integrative systems of medicine coupled with GHE would provide a sustainable path to achieve the goal of 'health for all'.

Keywords


Adverse Side Effects, Anti-Diabetic Drugs, Cost-Effective Treatment, Diabetes Type-1 and 2, Grand Health Ensurance Model, Health for all, TAG-Voluntary Health Service.

References





DOI: https://doi.org/10.18520/cs%2Fv112%2Fi12%2F2379-2385